跳至主要内容
临床试验/NCT07696624
NCT07696624尚未招募不适用

PRO-Active Rehabilitation Prior to Kidney Transplantation to ImproVe Patient-centered Recovery Evaluation

Ottawa Hospital Research Institute1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2027年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
45
试验地点
1
主要终点
Enrollment

研究概览

简要总结

The PRO-Active rehabilitation prior to Kidney Transplantation to ImproVe patient-centered recovery Evaluation trial tests an approach where people are supported to exercise, improve diet, and receive emotional support at home before and after kidney transplant surgery to understand the ideal process and benefits.

详细描述

Background: Many Canadians are waiting for a kidney transplant, using this wait time to improve health before surgery could mean better outcomes. Proactive rehabilitation (pro-hab) is an approach where people are supported to exercise, improve their diet, and have emotional support before surgery, and during their recovery at home.

Overarching Aim: The PROAKTIVE Pilot Trial will test an approach where people are supported to exercise, improve diet, and receive emotional support at home before and after kidney transplant surgery to understand the ideal process and benefits.

Methods:

Design, setting and participants: The PROAKTIVE Pilot trial is a single arm, prospective trial design where eligible participants are enrolled into the pro-hab program.

People >/= 18 years old who will undergo kidney transplant surgery will be included.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years
  • Scheduled, or on the pathway, for kidney transplant surgery
  • Expected surgery date between at least 4 weeks from enrollment
  • Access to internet-enabled device
  • Email address

排除标准

  • Inability to read and communicate in English
  • Cognitive impairment preventing ability to provide informed consent independently
  • No telephone/cell phone
  • Any of the following cardiovascular conditions:
  • Severe valvular heart disease that limits a patient's ability to ambulate on level ground, or is associated with syncope or dyspnea
  • Severe cardiac dysrhythmias that limit a patient's ability to ambulate on level ground, or is associated with syncope or dyspnea
  • Recent myocardial infarction (within 6 weeks prior to enrollment - based on the Heart and Stroke Foundation's HeartWalk program)

结局指标

主要结局

Enrollment

时间窗: One month

\>40% of eligible participants enroll (4/month) would allow us to complete a fully powered (n=312) patient trial in 24 months.

Adequate pro-hab program adherence

时间窗: A minimum of 4 weeks before surgery and 18 weeks after discharged from surgery

\>75% adherence is required to meaningfully benefit from multimodal health-promotion interventions.

Adequate patient-reported outcome follow up

时间窗: One year

\>90% complete outcome ascertainment ensures a low risk of bias trial in terms of non-missing data

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验